Angel Pharmaceuticals Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $14.7M

  • Investors
  • 5

Angel Pharmaceuticals General Information

Description

Developer of innovative pharmaceutical drugs designed to address unmet medical needs in cancer and autoimmune diseases. The company offers advanced drug discovery research, clinical development expertise, and novel therapeutic pipelines, enabling healthcare providers and patients to access targeted treatments that improve disease management outcomes.

Contact Information

Website
angelpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, Zhejiang Future Technology Research Institute
  • Number 152 Huixin Road, Nanhu District
  • Jiaxing, Zhejiang 314000
  • China
+86 0573
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6th Floor, Zhejiang Future Technology Research Institute
  • Number 152 Huixin Road, Nanhu District
  • Jiaxing, Zhejiang 314000
  • China
+86 0573

Angel Pharmaceuticals Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angel Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 10-Jun-2026 $14.7M Completed Generating Revenue
3. Secondary Transaction - Private 21-Sep-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Oct-2020 $41M $41M Completed Generating Revenue
1. Seed Round Completed Startup
To view Angel Pharmaceuticals’s complete valuation and funding history, request access »

Angel Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corvus Pharmaceuticals Corporation Minority
Betta Pharmaceuticals Corporation Minority
Hangzhou Tigermed Consulting Company Corporation Minority
Puissance Capital Management Asset Manager Minority
Zhejiang Hisun Pharmaceutical Company Corporation Minority
To view Angel Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Angel Pharmaceuticals FAQs

  • When was Angel Pharmaceuticals founded?

    Angel Pharmaceuticals was founded in 2020.

  • Where is Angel Pharmaceuticals headquartered?

    Angel Pharmaceuticals is headquartered in Jiaxing, China.

  • What industry is Angel Pharmaceuticals in?

    Angel Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Angel Pharmaceuticals a private or public company?

    Angel Pharmaceuticals is a Private company.

  • What is Angel Pharmaceuticals’s current revenue?

    The current revenue for Angel Pharmaceuticals is .

  • How much funding has Angel Pharmaceuticals raised over time?

    Angel Pharmaceuticals has raised $55.7M.

  • Who are Angel Pharmaceuticals’s investors?

    Corvus Pharmaceuticals, Betta Pharmaceuticals, Hangzhou Tigermed Consulting Company, Puissance Capital Management, and Zhejiang Hisun Pharmaceutical Company have invested in Angel Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process